New blood test method may predict Alzheimer's disease.
Reported March 2020 from the NIH - National Institutes of Health
An article published from the NIH states a new blood testing technique could help researchers detect Alzheimer's disease prior to onset or in those showing early signs of dementia. The approach could be less invasive and costly than current brain imaging and spinal fluid tests, enabling earlier treatments and testing of novel approaches.
"A team led by Dr. Adam Boxer at the University of California, San Francisco investigated whether a new blood testing technique called Simoa could be used to measure concentrations of tau and predict development of Alzheimer's disease. The study was funded in part by NIH's National Institute on Aging (NIA), National Institute of Neurological Disorders and Stroke (NINDS), and National Center for Advanced Translational Sciences (NCATS). Results were published online on March 2, 2020, in Nature Medicine."